160 related articles for article (PubMed ID: 35347237)
1. Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL.
Kameda K; Kako S; Kim SW; Usui Y; Kato K; Fukuda T; Uchida N; Kobayashi H; Wakayama T; Sakaida E; Yano S; Imada K; Nara M; Ikeda T; Fuchida SI; Ishikawa J; Sugahara H; Kanda J; Kimura T; Ichinohe T; Atsuta Y; Kondo E
Leukemia; 2022 May; 36(5):1361-1370. PubMed ID: 35347237
[TBL] [Abstract][Full Text] [Related]
2. Long-term Outcomes After Hematopoietic Cell Transplant in Peripheral T-Cell Lymphoma - The Oregon Health and Science University Experience.
Galligan D; Williamson S; Myers J; Chen AI; Hayes-Lattin B; Okada C; Spurgeon S; Maziarz R; Schachter L
Clin Lymphoma Myeloma Leuk; 2023 Dec; 23(12):874-881. PubMed ID: 37741763
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
Rogers AM; Brammer JE
Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515
[TBL] [Abstract][Full Text] [Related]
4. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H;
Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159
[TBL] [Abstract][Full Text] [Related]
5. The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
Park SI; Horwitz SM; Foss FM; Pinter-Brown LC; Carson KR; Rosen ST; Pro B; Hsi ED; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta M; Advani RH; Feldman T; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Shustov AR;
Cancer; 2019 May; 125(9):1507-1517. PubMed ID: 30694529
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.
Smith SM; Burns LJ; van Besien K; Lerademacher J; He W; Fenske TS; Suzuki R; Hsu JW; Schouten HC; Hale GA; Holmberg LA; Sureda A; Freytes CO; Maziarz RT; Inwards DJ; Gale RP; Gross TG; Cairo MS; Costa LJ; Lazarus HM; Wiernik PH; Maharaj D; Laport GG; Montoto S; Hari PN
J Clin Oncol; 2013 Sep; 31(25):3100-9. PubMed ID: 23897963
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.
Yamasaki S; Chihara D; Kim SW; Kawata T; Mizuta S; Ago H; Chou T; Yamane T; Uchiyama H; Oyake T; Miura K; Saito B; Taji H; Nakamae H; Miyamoto T; Fukuda T; Kanda J; Atsuta Y; Suzuki R
Int J Hematol; 2019 Feb; 109(2):175-186. PubMed ID: 30430419
[TBL] [Abstract][Full Text] [Related]
8. Outcome of Allogeneic and Autologous Hematopoietic Cell Transplantation for High-Risk Peripheral T Cell Lymphomas: A Retrospective Analysis From a Chinese Center.
Huang H; Jiang Y; Wang Q; Guo L; Jin Z; Fu Z; Han Y; Sun A; Liu W; Ruan J; Wu D
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1393-1397. PubMed ID: 28478121
[TBL] [Abstract][Full Text] [Related]
9. The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
Chihara D; Fanale MA; Miranda RN; Noorani M; Westin JR; Nastoupil LJ; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Lee HJ; Neelapu SS; Rodriguez MA; Wang M; Fowler NH; Davis RE; Medeiros LJ; Hosing C; Nieto YL; Oki Y
Br J Haematol; 2017 Mar; 176(5):750-758. PubMed ID: 27983760
[TBL] [Abstract][Full Text] [Related]
10. Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Kharfan-Dabaja MA; Kumar A; Ayala E; Hamadani M; Reimer P; Gisselbrecht C; d'Amore F; Jantunen E; Ishida T; Bazarbachi A; Foss F; Advani R; Fenske TS; Lazarus HM; Friedberg JW; Aljurf M; Sokol L; Tobinai K; Tse E; Burns LJ; Chavez JC; Reddy NM; Suzuki R; Ahmed S; Nademanee A; Mohty M; Gopal AK; Fanale MA; Pro B; Moskowitz AJ; Sureda A; Perales MA; Carpenter PA; Savani BN
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1826-1838. PubMed ID: 28797780
[TBL] [Abstract][Full Text] [Related]
11. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
Shustov A
Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
[TBL] [Abstract][Full Text] [Related]
12. Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy.
Chihara D; Oki Y; Ine S; Yamamoto K; Kato H; Taji H; Kagami Y; Yatabe Y; Nakamura S; Morishima Y
Leuk Lymphoma; 2009 Dec; 50(12):1999-2004. PubMed ID: 19860627
[TBL] [Abstract][Full Text] [Related]
13. Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers.
Fossard G; Broussais F; Coelho I; Bailly S; Nicolas-Virelizier E; Toussaint E; Lancesseur C; Le Bras F; Willems E; Tchernonog E; Chalopin T; Delarue R; Gressin R; Chauchet A; Gyan E; Cartron G; Bonnet C; Haioun C; Damaj G; Gaulard P; Fornecker L; Ghesquières H; Tournilhac O; da Silva MG; Bouabdallah R; Salles G; Bachy E
Ann Oncol; 2018 Mar; 29(3):715-723. PubMed ID: 29253087
[TBL] [Abstract][Full Text] [Related]
14. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.
Martín García-Sancho A; Rodríguez-Pinilla SM; Domingo-Domenech E; Climent F; Sánchez-Garcia J; López Jiménez J; García-Cosío Piqueras M; Castellvi J; González AJ; González de Villambrosia S; Gómez Codina J; Navarro B; Rodríguez G; Borrero JJ; Fraga M; Naves A; Baeza L; Córdoba R
Br J Haematol; 2023 Oct; 203(2):182-193. PubMed ID: 37386897
[TBL] [Abstract][Full Text] [Related]
15. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.
Mak V; Hamm J; Chhanabhai M; Shenkier T; Klasa R; Sehn LH; Villa D; Gascoyne RD; Connors JM; Savage KJ
J Clin Oncol; 2013 Jun; 31(16):1970-6. PubMed ID: 23610113
[TBL] [Abstract][Full Text] [Related]
16. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
Gkotzamanidou M; Papadimitriou CA
Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
[TBL] [Abstract][Full Text] [Related]
17. Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands.
Meeuwes FO; Brink M; Plattel W; Van der Poel MWM; Kersten MJ; Wondergem M; Böhmer L; Woei-A-Jin FJSH; Visser O; Oostvogels R; Jansen PM; Neelis KJ; Crijns APG; Daniëls LA; Snijders TJF; Vermaat JSP; Huls GA; Nijland M
Haematologica; 2024 Apr; 109(4):1163-1170. PubMed ID: 37794805
[TBL] [Abstract][Full Text] [Related]
18. Autologous stem cell transplant for refractory and relapsed peripheral T-cell lymphoma: a retrospective study in China.
Zhang C; Lv J; Deng J; Liu W; Wang X; Song Y; Zhu J
J Cancer; 2024; 15(2):539-544. PubMed ID: 38169559
[No Abstract] [Full Text] [Related]
19. Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking.
Cheng S; Zhang W; Inghirami G; Tam W
Elife; 2021 Sep; 10():. PubMed ID: 34581268
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Allogeneic Stem Cell Transplant and Autologous Stem Cell Transplant in Refractory or Relapsed Peripheral T-Cell Lymphoma: A Systematic Review and Meta-analysis.
Du J; Yu D; Han X; Zhu L; Huang Z
JAMA Netw Open; 2021 May; 4(5):e219807. PubMed ID: 34042995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]